Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.08M Sell
23,994
-1,121
-4% -$131K 1.8% 18
2026
Q1
$3.02M Sell
25,115
-1,328
-5% -$153K 2.16% 17
2025
Q4
$2.78M Buy
26,443
+563
+2% +$52.8K 2.11% 19
2025
Q3
$2.17M Buy
25,880
+1,539
+6% +$127K 1.78% 27
2025
Q2
$1.93M Buy
+24,341
New +$1.93M 1.82% 26

Other funds holding MRK

CFC Planning Company's MRK Position: Q2 2026 in Review

CFC Planning Company reduced its Merck (MRK) stake by 4.5% in Q2 2026, selling an estimated $131K and leaving 23,994 shares worth $3.08M. The position accounts for 1.8% of the portfolio, ranked #18.

CFC Planning Company first reported a position in MRK in Q2 2025 and has held it in 5 quarters since. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • CFC Planning Company held 23,994 shares of Merck worth $3.08M as of Q2 2026.
  • CFC Planning Company sold 1,121 Merck shares in Q2 2026, an estimated $131K.
  • Merck made up 1.8% of CFC Planning Company's portfolio in Q2 2026, its #18 holding.
  • CFC Planning Company first reported a position in Merck in Q2 2025 and has held it in 5 quarters since.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on CFC Planning Company's 13F filing for Q2 2026, filed 5 Aug 2026.